By Mill Chart
Last update: Nov 1, 2023
Growth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if DEXCOM INC (NASDAQ:DXCM) is suited for growth investing. Investors should of course do their own research, but we spotted DEXCOM INC showing up in our Louis Navellier growth screen, so it may be worth spending some more time on it.
ChartMill assigns a proprietary Fundamental Rating to each stock. The score is computed daily by evaluating various fundamental indicators and properties. The score ranges from 0 to 10.
DXCM gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 201 industry peers in the Health Care Equipment & Supplies industry. DXCM has an excellent profitability rating, but there are some minor concerns on its financial health. DXCM is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! With these ratings, DXCM could be worth investigating further for growth investing!.
Check the latest full fundamental report of DXCM for a complete fundamental analysis.
More growth stocks can be found in our Lois Navellier screen.
This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
DEXCOM INC
NASDAQ:DXCM (4/26/2024, 7:00:02 PM)
After market: 124.2 -0.14 (-0.11%)124.34
-13.67 (-9.91%)
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
Let's take a closer look at the S&P500 stocks with an unusual volume in today's session on Friday. Stay informed about the market activity below.
Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Friday.
Microsoft, Tesla, Google, GE and Chipotle were earnings winners. Meta was a notable loser.
Friday's session: gap up and gap down stock in the S&P500 index
DXCM earnings call for the period ending March 31, 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips DexCom (NASDAQ:DXCM) just reported results for the first quarter of 2024.DexCom...
DXCM stock results show that DexCom beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Which stocks are moving after the closing bell on Thursday?
The company raised the lower bound of its sales guidance for the year.
On Thursday, implantable lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier.